10.1038/s41467-017-01460-0 - Mutational and putative neoantigen lo...

This document has been corrected

Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma

10.1038/s41467-017-01460-0

Published Online: 2017-11-23

Journal: Nature Communications•Publisher: Springer Science and Business Media LLC

Authors: Anders Kvist•Frida Rosengren•Göran Jönsson•Inge Marie Svane•Johan Vallon-Christersson•Katja Harbst•Marco Donia•Markus Ringnér•Martin Lauss•Maryem Salim•Rikke Andersen•Shamik Mitra•Therese Törngren

This document has been corrected

Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma

10.1038/s41467-017-01460-0

Published Online: 2017-11-23

Journal: Nature Communications

NOW

2020-04-01•Correction

Author Correction: Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma

10.1038/s41467-020-15531-2

* information provided by CrossRef

2020-04-01•Correction

10.1038/s41467-020-15531-2

* information provided by CrossRef

2017-11-23•Published

2020-04-01•Correction

Author Correction: Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma

10.1038/s41467-020-15531-2

* information provided by CrossRef

This document has been corrected

Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma

10.1038/s41467-017-01460-0

Published Online: 2017-11-23

Journal: Nature Communications•Publisher: Springer Science and Business Media LLC